Skip to main content
logo
Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
0.9950
+0.0685 (7.39%)
At close: Nov 6, 2026, 4:00 PM EST
1.000
+0.005 (0.50%)
After-hours: Nov 6, 2026, 7:30 PM EST

Cardiol Therapeutics Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.08
Revenue Growth
------
Gross Profit
-----0.08
Selling, General & Admin
20.1820.326.2615.5622.3727.87
Research & Development
15.6714.0214.0114.2218.9610.87
Operating Expenses
35.8634.3240.2829.7941.3438.74
Operating Income
-35.86-34.32-40.28-29.79-41.34-38.66
Interest & Investment Income
0.70.731.192.041.240.11
Currency Exchange Gain (Loss)
0.3-1.182.14-0.712.761.89
Other Non Operating Income (Expenses)
0.780.950.270.336.415.03
Pretax Income
-34.08-33.82-36.68-28.13-30.93-31.64
Net Income
-34.08-33.82-36.68-28.13-30.93-31.64
Net Income to Common
-34.08-33.82-36.68-28.13-30.93-31.64
Net Income Growth
------
Shares Outstanding (Basic)
1028772646343
Shares Outstanding (Diluted)
1028772646343
Shares Change
28.88%21.55%11.02%3.13%44.61%44.77%
EPS (Basic)
-0.34-0.39-0.51-0.44-0.49-0.73
EPS (Diluted)
-0.34-0.39-0.51-0.44-0.49-0.73
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-24.1-23.88-25.08-25.24-27.3-23.55
Free Cash Flow Per Share
-0.24-0.28-0.35-0.39-0.44-0.55
Gross Margin
-----100.00%
Operating Margin
------49091.93%
Profit Margin
------40170.45%
Free Cash Flow Margin
------29904.22%
EBITDA
-35.85-34.28-39.97-29.59-41.16-38.44
D&A For EBITDA
0.010.040.310.20.180.22
EBIT
-35.86-34.32-40.28-29.79-41.34-38.66
SEC Filings: 10-K · 10-Q